CIS 2023 Annual Meeting

Information on how to access the virtual platform was sent on 5/17/2023 to the email address you registered with. If you did not receive this email (and it is not in your junk folder), please contact support@showgear.com.
 

Welcome to the 2023 Clinical Immunology Society Annual Meeting: Immune Deficiency & Dysregulation North American Conference. The 2023 Annual Meeting will once again be held as a hybrid meeting, with the option to attend virtually or in-person in St. Louis, Missouri!

On behalf of the Program Committee and CIS leadership, we are excited to welcome attendees to the 2023 Annual Meeting!  We understand that these times continue to be challenging, and that attending meetings, especially in person, may not be feasible for all our attendees. The leadership of CIS and the program committee are committed to ensuring that the greatest number of individuals who hope to attend the Annual Meeting are able to despite the ongoing situation with COVID-19 and are happy to announce the 2023 meeting will be held as a hybrid meeting once again!

The primary goal of the Annual Meeting is to provide a stimulating and lively forum for presentation and discussion of the latest advances in clinical immunology, including primary immunodeficiencies and immune dysregulatory diseases, and related areas, including molecular pathogenesis, and novel therapeutic approaches.

The conference will focus on cutting edge clinical and basic science research, as well as practical applications of these in patient care. The plenary sessions of the conference are specifically designed to tackle key issues facing physicians and scientists in the field of clinical immunology, while also exploring its inter-connectedness to other medical disciplines and healthcare in general, and addressing the challenges and benefits of new diagnostic tools, and therapeutic options currently available for personalized treatment of patients with rare immunological disorders. The sessions will also provide a venue for lively dialogue on the growing field of secondary immunodeficiencies, and the future of immunomodulatory therapies. 

The ultimate goal of the Annual CIS meeting is to engage, educate and generate a large and collaborative network of clinical immunology physicians and scientists, in a manner that is consistent with the overarching aims of the Clinical Immunology Society, and equip them for clinical practice and research in this field.

We look forward to seeing you in St. Louis or virtually!

Sergio Rosenzweig, MD, PhD NIH Clinical Center CIS President 2023 Program Co-Chair	Lisa Forbes Satter, MD Baylor College of Medicine 2023 Program Co-Chair	Carrie Lucas, PhD Yale University 2023 Program Co-Chair